Key facts
- It has raised $28.0M; the latest was Later Stage VC ($18.0M) in Feb 2025.
- Notable investors include Elevation Capital (India), Tata Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Cellcure Cancer Centre
- ·The full record, as it builds
Funding rounds
No funding rounds for Cellcure Cancer Centre are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cellcure Cancer Centre
Operator of a cancer care center chain intended to provide affordable quality care. The company specializes in daycare centers, in-house pathology, bone marrow evaluation, in-house pharmacy, and palliative care and offers oncology and hematology healthcare services, enabling patients with tailormade treatment options to suit their specific needs for cancer treatment.
- Sector
- Healthcare
- HQ
- Mumbai, India
- Founded
- 2018
- Website
- mocindia.co.in/
- Ownership
- Privately Held (backing)
Cellcure Cancer Centre doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cellcure Cancer Centre shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cellcure Cancer Centre in its N-PORT filings yet. We sweep new filings monthly.